Back to Search
DANA GABUZDA, M.D.
M.D.
Research Study Specialist
NPI: 1487856134Individual
Specialties, Licenses & Credentials
Research Study SpecialistPrimary
Specialist — Research Study
Code: 1744R1102X
54386(MA)
Research & Publications (20)
A zinc-binding region in Vif binds Cul5 and determines cullin selection.
PMID 16636053·J Biol Chem·2006
8-other
Elicitation from virus-naive individuals of cytotoxic T lymphocytes directed against conserved HIV-1 epitopes.
PMID 16674822·Med Immunol·2006
8-other
Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis.
PMID 10871762·J Neurovirol·2000
6-review
Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.
PMID 19321618·J Virol·2009
8-other
Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.
PMID 19343205·PLoS Pathog·2009
7-preclinical
Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.
PMID 19109396·J Virol·2009
7-preclinical
Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12.
PMID 19619305·Retrovirology·2009
8-other
Evolution of the aging brain transcriptome and synaptic regulation.
PMID 18830410·PLoS One·2008
7-preclinical
The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
PMID 18462066·DNA Cell Biol·2008
8-other
Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.
PMID 18575590·PLoS One·2008
8-other
Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues.
PMID 18788913·AIDS Res Hum Retroviruses·2008
5-case
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.
PMID 17888184·Retrovirology·2007
8-other
Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.
PMID 17898068·J Virol·2007
8-other
Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source.
PMID 17634131·Virol J·2007
8-other
Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia.
PMID 17599380·Virology·2007
7-preclinical
Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.
PMID 17239419·Virology·2007
8-other
High frequency of defective vpu compared with tat and rev genes in brain from patients with HIV type 1-associated dementia.
PMID 17451348·AIDS Res Hum Retroviruses·2007
4-observational
Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions.
PMID 17567690·J Virol·2007
8-other
Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.
PMID 18076768·Retrovirology·2007
8-other
Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.
PMID 17084877·Virology·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST # JF816, DANA-FARBER CANCER INSTITUTE
BOSTON, MA 02115 - Phone
- (617) 632-2154
Quick Facts
- NPI
- 1487856134
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile